honokiol has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balan, M; Pal, S; Rawat, L; Sabarwal, A; Sasamoto, Y | 1 |
| Castillo, V; Cheng, S; Eliaz, I; Sliva, D | 1 |
2 other study(ies) available for honokiol and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress.
Topics: Carcinoma, Renal Cell; Heme Oxygenase-1; Humans; Kidney Neoplasms; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2023 |
Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Kisspeptins; Lignans; Neoplasm Invasiveness; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Signal Transduction | 2015 |